WinstonWınston
Syra Health Corp. Class A Common Stock logo

Syra Health Corp. Class A Common Stock

SYRA
33
Medical - Care Facilities · Healthcare
Price
$0.81
+0.05 (+6.34%)
Market Cap
$9.2M
Winston Score
33
Winston is serious
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+62.8% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 7.3M (2021) → 11.9M (2025)

Syra Health Corp. is a small healthcare services company that focuses on public health workforce solutions and behavioral health programs. It provides services like healthcare staffing, mental health support, and population health management, mainly to government agencies and healthcare organizations. The company operates in the growing area of community and public health, where demand for mental health and workforce services has increased significantly in recent years.

Syra Health makes money by charging fees for its staffing and consulting services, largely through government contracts. It operates primarily in the United States and, with a market cap near zero, is a very small company with limited financial scale. The company is currently unprofitable at the operating level, which is a real risk given its reliance on contract renewals and government funding. The key growth driver is expanding its contract base across more states and agencies, but competition from larger, better-funded healthcare staffing firms makes that a difficult path.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+22.4% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

+131.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$67,840/ year

Declining (-88% vs prior year)

0.9% of revenue

Below sector average (18%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

17.7%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$3M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Syra Health Corp. Class A Common Stock is a rare growth stock that's already generating positive cash flow while growing at 22%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
42.7%
Healthy — 42.7% gross margin
Operating Margin
8.4%
Modest — 8.4% operating margin
ROCE
7.8%
Weak — 7.8% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-5.5%
Shrinking sales (-5.5% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
9.9%
Modest free cash flow (9.9%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.03
Conservative — low debt load (0.03)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial